TFO
ABMD

Tarbox Family Office’s Abiomed Inc ABMD Stock Holding History

Tarbox Family Office’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-18
Closed -$6K – 1074
2022
Q1 		$6K Buy
18
+7
+64% +$2.15K ﹤0.01% 510
2021
Q4 		$4K Hold
11
– – ﹤0.01% 728
2021
Q3 		$4K Hold
11
– – ﹤0.01% 747
2021
Q2 		$3K Hold
11
– – ﹤0.01% 878
2021
Q1 		$4K Hold
11
– – ﹤0.01% 694
2020
Q4 		$4K Hold
11
– – ﹤0.01% 638
2020
Q3 		$3K Hold
11
– – ﹤0.01% 691
2020
Q2 		$3K Buy
+11
New +$2.21K ﹤0.01% 686
2020
Q1 		– Sell
-11
Closed -$2K – 1381
2019
Q4 		$2K Buy
+11
New +$2.04K ﹤0.01% 888

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Tarbox Family Office's ABMD Position: Q2 2022 in Review

Tarbox Family Office sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 18 shares — an estimated $6K sold.

Tarbox Family Office first reported a position in ABMD in Q4 2019 and held it in 9 quarters. The position peaked at $6K in Q1 2022. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

  • Tarbox Family Office reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
  • Tarbox Family Office sold 18 Abiomed Inc shares in Q2 2022, an estimated $6K.
  • Tarbox Family Office first reported a position in Abiomed Inc in Q4 2019 and held it in 9 quarters.
  • Tarbox Family Office's Abiomed Inc position peaked at $6K in Q1 2022.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.